Yoshiyasu Kisaka

782 total citations
24 papers, 552 citations indexed

About

Yoshiyasu Kisaka is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, Yoshiyasu Kisaka has authored 24 papers receiving a total of 552 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Hepatology, 19 papers in Epidemiology and 6 papers in Surgery. Recurrent topics in Yoshiyasu Kisaka's work include Liver Disease Diagnosis and Treatment (19 papers), Hepatocellular Carcinoma Treatment and Prognosis (14 papers) and Hepatitis C virus research (8 papers). Yoshiyasu Kisaka is often cited by papers focused on Liver Disease Diagnosis and Treatment (19 papers), Hepatocellular Carcinoma Treatment and Prognosis (14 papers) and Hepatitis C virus research (8 papers). Yoshiyasu Kisaka collaborates with scholars based in Japan and United States. Yoshiyasu Kisaka's co-authors include Yoichi Hiasa, Masashi Hirooka, Morikazu Onji, Masanori Abe, Bunzo Matsuura, Yohei Koizumi, Takahide Uehara, Kojiro Michitaka, Hidehiro Murakami and Teru Kumagi and has published in prestigious journals such as Radiology, Mayo Clinic Proceedings and American Journal of Roentgenology.

In The Last Decade

Yoshiyasu Kisaka

24 papers receiving 540 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yoshiyasu Kisaka Japan 13 445 382 146 63 56 24 552
V. Cartier France 9 424 1.0× 494 1.3× 128 0.9× 78 1.2× 56 1.0× 14 660
Chie Tatsumi Japan 13 534 1.2× 390 1.0× 127 0.9× 123 2.0× 47 0.8× 16 677
Eugenia Peri Italy 9 418 0.9× 317 0.8× 159 1.1× 70 1.1× 78 1.4× 10 548
Hiroyuki Takabatake Japan 10 452 1.0× 407 1.1× 157 1.1× 53 0.8× 44 0.8× 38 599
Youichi Morimoto Japan 9 449 1.0× 417 1.1× 146 1.0× 44 0.7× 33 0.6× 27 532
Claire Castain France 7 185 0.4× 247 0.6× 92 0.6× 70 1.1× 51 0.9× 20 446
V. Dries Germany 10 213 0.5× 260 0.7× 110 0.8× 46 0.7× 36 0.6× 19 419
Barbara Schellhaas Germany 13 306 0.7× 288 0.8× 93 0.6× 99 1.6× 32 0.6× 29 428
Carmine Coppola Italy 16 466 1.0× 359 0.9× 140 1.0× 65 1.0× 68 1.2× 32 617
Yu Yoshimasu Japan 12 322 0.7× 412 1.1× 139 1.0× 141 2.2× 31 0.6× 32 619

Countries citing papers authored by Yoshiyasu Kisaka

Since Specialization
Citations

This map shows the geographic impact of Yoshiyasu Kisaka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yoshiyasu Kisaka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yoshiyasu Kisaka more than expected).

Fields of papers citing papers by Yoshiyasu Kisaka

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yoshiyasu Kisaka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yoshiyasu Kisaka. The network helps show where Yoshiyasu Kisaka may publish in the future.

Co-authorship network of co-authors of Yoshiyasu Kisaka

This figure shows the co-authorship network connecting the top 25 collaborators of Yoshiyasu Kisaka. A scholar is included among the top collaborators of Yoshiyasu Kisaka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yoshiyasu Kisaka. Yoshiyasu Kisaka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Watanabe, Takao, Yoshio Tokumoto, Kouji Joko, et al.. (2021). AFP and eGFR are related to early and late recurrence of HCC following antiviral therapy. BMC Cancer. 21(1). 699–699. 14 indexed citations
3.
Watanabe, Takao, Yoshio Tokumoto, Kouji Joko, et al.. (2020). Sex difference in the development of hepatocellular carcinoma after direct‐acting antiviral therapy in patients with HCV infection. Journal of Medical Virology. 92(12). 3507–3515. 6 indexed citations
4.
Kumagi, Teru, Tomoyuki Yokota, Nobuaki Azemoto, et al.. (2019). Early Detection of Pancreatic Cancer in Patients With Chronic Liver Disease Under Hepatocellular Carcinoma Surveillance. Mayo Clinic Proceedings. 94(10). 2004–2010. 6 indexed citations
5.
Watanabe, Takao, Yoshio Tokumoto, Kouji Joko, et al.. (2018). Predictors of hepatocellular carcinoma occurrence after direct‐acting antiviral therapy in patients with hepatitis C virus infection. Hepatology Research. 49(2). 136–146. 45 indexed citations
6.
Hirooka, Masashi, Atsushi Hiraoka, Hironori Ochi, et al.. (2018). Transcatheter Arterial Chemoembolization With or Without Radiofrequency Ablation: Outcomes in Patients With Barcelona Clinic Liver Cancer Stage B Hepatocellular Carcinoma. American Journal of Roentgenology. 210(4). 891–898. 31 indexed citations
7.
Hiraoka, Atsushi, Takashi Kumada, Kojiro Michitaka, et al.. (2017). Clinical features of hemodialysis patients treated for hepatocellular carcinoma: Comparison between resection and radiofrequency ablation. Molecular and Clinical Oncology. 6(4). 455–461. 7 indexed citations
8.
Watanabe, Takao, Kouji Joko, Kojiro Michitaka, et al.. (2016). Simeprevir with peginterferon/ribavirin for patients with hepatitis C virus genotype 1: high frequency of viral relapse in elderly patients. SpringerPlus. 5(1). 518–518. 3 indexed citations
9.
Koizumi, Yohei, Masashi Hirooka, Takahide Uehara, et al.. (2011). Transcatheter arterial chemoembolization with fine-powder cisplatin-lipiodol for HCC.. PubMed. 58(106). 512–5. 3 indexed citations
10.
Hirooka, Masashi, Hironori Ochi, Yohei Koizumi, et al.. (2011). Splenic Elasticity Measured with Real-time Tissue Elastography Is a Marker of Portal Hypertension. Radiology. 261(3). 960–968. 68 indexed citations
11.
Koizumi, Yohei, Masashi Hirooka, Yoshiyasu Kisaka, et al.. (2011). Liver Fibrosis in Patients with Chronic Hepatitis C: Noninvasive Diagnosis by Means of Real-time Tissue Elastography—Establishment of the Method for Measurement. Radiology. 258(2). 610–617. 117 indexed citations
12.
Kisaka, Yoshiyasu, Masanori Abe, Yoshio Tokumoto, et al.. (2010). CONGENITAL HEPATIC FIBROSIS WITHOUT ANY SYMPTOMS AS DIAGNOSED BY LAPAROSCOPY. Digestive Endoscopy. 22(4). 357–359. 3 indexed citations
13.
Hirooka, Masashi, Yohei Koizumi, Yoshiyasu Kisaka, et al.. (2010). Mass Reduction by Radiofrequency Ablation Before Hepatic Arterial Infusion Chemotherapy Improved Prognosis for Patients With Huge Hepatocellular Carcinoma and Portal Vein Thrombus. American Journal of Roentgenology. 194(2). W221–W226. 25 indexed citations
14.
Uehara, Takahide, Masashi Hirooka, Yoshiyasu Kisaka, et al.. (2009). Usefulness of the hyperechoic rim for assessing the therapeutic efficacy of radiofrequency ablation in hepatocellular carcinoma patients. Hepatology Research. 39(10). 954–962. 6 indexed citations
15.
Hirooka, Masashi, Yoshiyasu Kisaka, Takahide Uehara, et al.. (2009). EFFICACY OF LAPAROSCOPIC RADIOFREQUENCY ABLATION FOR HEPATOCELLULAR CARCINOMA COMPARED TO PERCUTANEOUS RADIOFREQUENCY ABLATION WITH ARTIFICIAL ASCITES. Digestive Endoscopy. 21(2). 82–86. 25 indexed citations
16.
Hirooka, Masashi, Yoshiyasu Kisaka, Takahide Uehara, et al.. (2008). Doppler Waveform Pattern Changes in a Patient with Primary Budd-Chiari Syndrome before and after Angioplasty. Internal Medicine. 47(2). 91–95. 5 indexed citations
17.
Michitaka, Kojiro, Yoshio Tokumoto, Kazuhiro Uesugi, et al.. (2008). Neuropsychiatric dysfunction in patients with chronic hepatitis and liver cirrhosis. Hepatology Research. 38(11). 1069–1075. 13 indexed citations
18.
Hirooka, Masashi, Yoshiyasu Kisaka, Takahide Uehara, et al.. (2008). Efficacy of splenectomy for hypersplenic patients with advanced hepatocellular carcinoma. Hepatology Research. 38(12). 1172–1177. 19 indexed citations
19.
Uehara, Takahide, Masashi Hirooka, Atsushi Hiraoka, et al.. (2007). Percutaneous ultrasound-guided radiofrequency ablation of hepatocellular carcinoma with artificially induced pleural effusion and ascites. Journal of Gastroenterology. 42(4). 306–311. 79 indexed citations
20.
Kisaka, Yoshiyasu, Teru Kumagi, Takahide Uehara, et al.. (2006). Usefulness of contrast‐enhanced ultrasonography with abdominal virtual ultrasonography in assessing therapeutic response in hepatocellular carcinoma treated with radiofrequency ablation. Liver International. 26(10). 1241–1247. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by V. Cartier Breakdown of academic impact, for papers by Chie Tatsumi Breakdown of academic impact, for papers by Eugenia Peri Breakdown of academic impact, for papers by Hiroyuki Takabatake Breakdown of academic impact, for papers by Youichi Morimoto Breakdown of academic impact, for papers by Claire Castain Breakdown of academic impact, for papers by V. Dries Breakdown of academic impact, for papers by Barbara Schellhaas Breakdown of academic impact, for papers by Carmine Coppola Breakdown of academic impact, for papers by Yu Yoshimasu
Rankless by CCL
2026